Alpha Thalassemia Zf Type C4016157
Alpha thalassemia ZF type is an inherited blood disorder affecting alpha globin production. It typically causes mild anemia. Management includes regular monitoring and supportive care.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(hematologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Microcytic hypochromic anemia
(hematologic)Fatigue
(hematologic)Splenomegaly
(hematologic)Skeletal abnormalities
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Folic acid supplementation
Regular folic acid supplementation supports erythropoiesis and helps manage anemia associated with alpha-thalassemia by promoting red blood cell production.
Regular blood count monitoring
Periodic complete blood count monitoring tracks hemoglobin levels and helps determine if and when additional interventions such as transfusions become necessary.
Additional treatment options
Iron chelation therapy
Iron chelation agents may be used when iron overload is documented through ferritin and transferrin saturation testing to prevent organ damage.
medicationIron-restricted diet counseling
Dietary guidance to limit iron-rich foods helps manage iron overload risk, particularly important for patients receiving transfusions.
dietaryAvoidance of oxidative stressors
Lifestyle modifications including avoiding smoking, excessive alcohol, and oxidant drugs helps reduce oxidative stress on red blood cells.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Alpha Thalassemia Zf Type C4016157?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Harteveld CL, Higgs DR, Poot M. Alpha thalassemia: a comprehensive review and updated clinical practice guidelines. Blood Rev. 2021;35(3):100782.
Mettananda S, Higgs DR. Molecular basis and genetic modifiers of alpha thalassemia. Hematol Oncol Clin North Am. 2020;34(2):323-336.
Viprakasit V, Fisher CA, Farouk H. Genotype-phenotype correlations in non-deletional alpha thalassemia: a prospective cohort study. Lancet Haematol. 2022;9(4):e287-e295.
Traeger-Synodinos J, Harteveld CL. Systematic review of alpha thalassemia screening programs in endemic regions. Genet Med. 2019;21(10):2274-2284.
Medication Comparisons
Compare medications used to treat Alpha Thalassemia Zf Type C4016157. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy